Showing 61-70 out of 123
Page 7 of 13« First«...56789...»Last »
Assessing the Utility of Existing Hereditary Angioedema Disease Models for Health Economic Evaluation of Future TherapiesSchwander B, Lahue BJ, Cribbs KA, Czado S
ISPOR 2023
Assessing the Burden of Injection with Parenteral Hereditary Angioedema TherapiesSoteres DF, Cribbs KA, Czado S
ISPOR 2023
Rationale for the Short-term Prophylaxis Regimen with Sebetralstat in KONFIDENT-SIverson M, Duckworth E, Hansen E, Hampton SL, Smith MD, Audhya PK, Yea CM
C1 Inhibitor Workshop 2023
HAE Patients Decision to Carry On-demand Treatment When Away from HomeBetschel S, van Kooten S, Heckmann M, Danese S, Goga L, Guilarte M
C1 Inhibitor Workshop 2023
Route of Administration Preferences of People with Hereditary Angioedema for On-demand Treatment: A US-based Qualitative StudyDesai V, Ledia Goga L, Czado S, Brown M, Myers K, Bukstein D, Audhya PK, Bouillet L
C1 Inhibitor Workshop 2023
Assessing the Potential Benefits of Oral Therapies in Hereditary AngioedemaSoteres DF, Cribbs KA, Guo W, Czado S
AMCP 2023
Treatment with Sebetralstat Reduces the Cumulative Symptom Severity of Hereditary Angioedema Attacks in a Phase 2 TrialBernstein JA, Riedl MA, Lumry WR, Audhya PK, Smith MD, Yea CM
AAAAI 2023
A Comparative Bioavailability of Sebetralstat Following Administration of Orally Disintegrating Tablets and Film-Coated Tablets in Healthy VolunteersSmith MD, Iverson M, Hansen E, Audhya PK, Yea CM
AAAAI 2023
Anxiety Associated With Parenteral On-demand Treatment For Hereditary Angioedema (HAE)Burnette A, Anderson J, Longhurst H, van Kooten S, Heckmann M, Danese S, Goga L
AAAAI 2023
Patient Perspectives On Early Use Of On-demand Treatment For Hereditary Angioedema (HAE) Attacks to Reduce Severity and DurationRadojicic C, Manning M, Guilarte M, Heckmann M, van Kooten S, Danese S, Goga L
AAAAI 2023
